These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 17169024)

  • 1. Alterations in surfactant protein A form and clearance during Pneumocystis pneumonia.
    Lasbury ME; Durant PJ; Wang SH; Zhang C; Liao CP; Tschang D; Lee CH
    J Eukaryot Microbiol; 2006; 53 Suppl 1():S119-21. PubMed ID: 17169024
    [No Abstract]   [Full Text] [Related]  

  • 2. Inflammatory cells are sources of polyamines that induce alveolar macrophage to undergo apoptosis during Pneumocystis pneumonia.
    Liao CP; Lasbury ME; Wang SH; Zhang C; Durant PJ; Tschang D; Lee CH
    J Eukaryot Microbiol; 2006; 53 Suppl 1():S134-5. PubMed ID: 17169031
    [No Abstract]   [Full Text] [Related]  

  • 3. Expression and activation of complement protein and alveolar damage during Pneumocystis pneumonia.
    Lasbury ME; Durant PJ; Tschang D; Wang SH; Zhang C; Liao CP; Lee CH
    J Eukaryot Microbiol; 2006; 53 Suppl 1():S136-7. PubMed ID: 17169032
    [No Abstract]   [Full Text] [Related]  

  • 4. Transforming growth factor-beta activation and signaling in the alveolar environment during Pneumocystis pneumonia.
    Ray CA; Lasbury ME; Durant PJ; Wang SH; Zhang C; Liao CP; Tschang D; Lee CH
    J Eukaryot Microbiol; 2006; 53 Suppl 1():S127-9. PubMed ID: 17169028
    [No Abstract]   [Full Text] [Related]  

  • 5. Alteration of surfactant proteins A and D in bronchoalveolar lavage fluid of Pneumocystis carinii pneumonia.
    Qu J; He L; Rong Z; Pan J; Chen X; Morrison DC; Li X
    Chin Med J (Engl); 2001 Nov; 114(11):1143-6. PubMed ID: 11729507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of plasminogen activator by alveolar macrophages in experimental Pneumocystis carinii pneumonia.
    Angelici E; Contini C; Spezzano M; Romani R; Carfagna P; Serra P; Canipari R
    J Eukaryot Microbiol; 1999; 46(5):149S. PubMed ID: 10519296
    [No Abstract]   [Full Text] [Related]  

  • 7. GM-CSF expression in the lung during Pneumocystis pneumonia.
    Lasbury ME; Durant PJ; Wang SH; Zhang C; Liao CP; Tschang D; Lee CH
    J Eukaryot Microbiol; 2006; 53 Suppl 1():S124-6. PubMed ID: 17169027
    [No Abstract]   [Full Text] [Related]  

  • 8. Syndecan-1 expression in the lung during Pneumocystis infection.
    Wang SH; Zhang C; Liao CP; Lasbury ME; Durant PJ; Tschang D; Lee CH
    J Eukaryot Microbiol; 2006; 53 Suppl 1():S122-3. PubMed ID: 17169026
    [No Abstract]   [Full Text] [Related]  

  • 9. Surfactant protein-D modulates interaction of Pneumocystis carinii with alveolar macrophages.
    Limper AH; Crouch EC; O'Riordan DM; Chang D; Vuk-Pavlovic Z; Standing JE; Kwon KY; Adlakha A
    J Lab Clin Med; 1995 Nov; 126(5):416-22. PubMed ID: 7595025
    [No Abstract]   [Full Text] [Related]  

  • 10. Surfactant protein binding to Pneumocystis carinii organisms.
    Pottratz ST
    J Lab Clin Med; 1995 Nov; 126(5):414-5. PubMed ID: 7595024
    [No Abstract]   [Full Text] [Related]  

  • 11. Survival pathway signal transduction is reduced in alveolar macrophages during Pneumocystis pneumonia.
    Lasbury ME; Ray CA; Durant PJ; Wang SH; Zhang C; Liao CP; Tschang D; Lee CH
    J Eukaryot Microbiol; 2006; 53 Suppl 1():S130-1. PubMed ID: 17169029
    [No Abstract]   [Full Text] [Related]  

  • 12. Recovery from Pneumocystis carinii pneumonia in dexamethasone-treated Wistar rats.
    Sukura A; Konttinen YT; Sepper R; Lindberg LA
    Eur Respir J; 1995 May; 8(5):701-8. PubMed ID: 7656938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of alveolar macrophage apoptosis prolongs survival of rats and mice with pneumocystis pneumonia.
    Lasbury ME; Durant PJ; Ray CA; Tschang D; Schwendener R; Lee CH
    J Immunol; 2006 Jun; 176(11):6443-53. PubMed ID: 16709801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pneumocystis carinii factor responsible for reduced phagocytic activity in alveolar macrophages.
    Lasbury ME; Lin PM; Tschang D; Durant PJ; Lee CH
    J Eukaryot Microbiol; 2003; 50 Suppl():641-2. PubMed ID: 14736197
    [No Abstract]   [Full Text] [Related]  

  • 15. Accumulation of surfactant protein D in the lung during Pneumocystis carinii pneumonia.
    Limper AH; O'Riordan DM; Vuk-Pavlovic Z; Crouch EC
    J Eukaryot Microbiol; 1994; 41(5):98S. PubMed ID: 7804292
    [No Abstract]   [Full Text] [Related]  

  • 16. Alveolar response to experimental Pneumocystis carinii pneumonia in the rat.
    Lanken PN; Minda M; Pietra GG; Fishman AP
    Am J Pathol; 1980 Jun; 99(3):561-88. PubMed ID: 6966893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptor 2 knockout reduces lung inflammation during Pneumocystis pneumonia but has no effect on phagocytosis of Pneumocystis organisms by alveolar macrophages.
    Zhang C; Wang SH; Liao CP; Lasbury ME; Durant PJ; Tschang D; Lee CH
    J Eukaryot Microbiol; 2006; 53 Suppl 1():S132-3. PubMed ID: 17169030
    [No Abstract]   [Full Text] [Related]  

  • 18. Surfactant pretreatment decreases long-term damage after ischemia-reperfusion injury of the lung.
    van der Kaaij NP; Kluin J; Haitsma JJ; den Bakker MA; Lambrecht BN; Lachmann B; de Bruin RW; Bogers AJ
    Eur J Cardiothorac Surg; 2009 Feb; 35(2):304-12; discussion 312. PubMed ID: 19109031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bronchoalveolar lavage fluid from Pneumocystis carinii-infected rats inhibits phagocytosis in normal alveolar macrophages.
    Lasbury ME; Durant PJ; Lee CH
    J Eukaryot Microbiol; 2001; Suppl():163S-164S. PubMed ID: 11906045
    [No Abstract]   [Full Text] [Related]  

  • 20. Caspase-9 as a target for Pneumocystis pneumonia therapy.
    Lasbury ME; Wang SH; Zhang C; Liao CP; Durant PJ; Tschang D; Lee CH
    J Eukaryot Microbiol; 2006; 53 Suppl 1():S138-9. PubMed ID: 17169033
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.